Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Bionomous | 2024 | Debt Financing | Undisclosed | Villaz-saint-pierre |
| Locatee | 2021 | Series B | Undisclosed | Zürich |
| IDUN Technologies | 2021 | Seed | Undisclosed | Opfikon |
| Proteomedix | 2021 | Debt Financing | Undisclosed | Schlieren |
| Nanolive | 2022 | Series C | Undisclosed | Ecublens |
| Adaptyv Biosystems | 2025 | Seed | Undisclosed | Lausanne |
| Insolight | 2025 | Debt Financing | Undisclosed | Lausanne |
| Resistell AG | 2025 | Grant | Undisclosed | Basel |
| Synendos Therapeutics | 2025 | Grant | Undisclosed | Allschwil |
| INERGIO | 2025 | Grant | Undisclosed | Lausanne |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Bionomous | Debt Financing | Undisclosed | Villaz-saint-pierre, Switzerland |
| 2 | Locatee | Series B | Undisclosed | Zürich, Switzerland |
| 3 | IDUN Technologies | Seed | Undisclosed | Opfikon, Switzerland |
| 4 | Proteomedix | Debt Financing | Undisclosed | Schlieren, Switzerland |
| 5 | Nanolive | Series C | Undisclosed | Ecublens, Switzerland |
| 6 | Adaptyv Biosystems | Seed | Undisclosed | Lausanne, Switzerland |
| 7 | Insolight | Debt Financing | Undisclosed | Lausanne, Switzerland |
| 8 | Resistell AG | Grant | Undisclosed | Basel, Switzerland |
| 9 | Synendos Therapeutics | Grant | Undisclosed | Allschwil, Switzerland |
| 10 | INERGIO | Grant | Undisclosed | Lausanne, Switzerland |
Bionomous automates the screening, sorting, and plating of miniature biological entities to accelerating science
Locatee is a workplace analytics solution that transforms data into space utilization insights.
IDUN Technologies is developing the Internet of Humans, a world where devices and apps react to your emotional needs.
Proteomedix (an Onconetix company; NASDAQ:ONCO) is a healthcare company whose mission is to transform prostate cancer diagnosis.
Nanolive has developed a disruptive proprietary technology.
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics.
Insolight is an energy company that develops and manufactures solar panels.
Resistell is a antibiotic resistance test.
Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.
INERGIO is a reliable power power supply yet is a challenge to off-grid systems.
csky.ai specializes in using Edge AI technologies to enrich even the most sensitive discussions.
Orio Therapeutics is a biotechnology research company that offers treatment and medication support for patients with myocardial infarction.
Zaphiro has developed a real-time monitoring and automation system that enhances the efficiency and profitability of grid operations.
The most comprehensive blood test, via multi-omics and AI, for disease risk identification and prevention planning.
Logmind is an AI-accelerated log data analytics platform for the visibility and automated insights into unstructured log data.
Scrona is a manufacturing company that focuses on developing a wide range of semiconductor products.
Auxivo is developing a new generation of wearable exoskeletons that support and protect workers.
Scanvio offers AI-augmented ultrasound software for faster endometriosis diagnosis.
AskEarth builds an agentic AI answer engine that makes satellite and geospatial intelligence accessible company-wide.
Scantrust is a supply chain software platform enabling product authentication, QR traceability, and anti-counterfeit protection.
Biosimo Chemicals produces sustainable chemicals
Hi-D Imaging develops technologies for cardiovascular operations with their fully automated medical image processing software.
CREAL develops near-eye light-field display bringing true optical depth and better immersion into virtual and mixed reality.
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.
Venture Kick has invested in 375 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Venture Kick's top investment sectors include Health Care, Biotechnology, Health Diagnostics, Medical, Information Technology. The firm invests across 53 different industry categories.
Venture Kick's average investment size is $6.1M across its portfolio of 375 companies.
Recent Venture Kick portfolio additions include Bionomous, Locatee, IDUN Technologies, Proteomedix, Nanolive. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors